These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 29467063)

  • 21. Medicare diabetes education benefit: HCFA plan excludes pharmacy.
    Schulke DG
    J Am Pharm Assoc (Wash); 1998; 38(4):393-4. PubMed ID: 9707946
    [No Abstract]   [Full Text] [Related]  

  • 22. Health care reform law offers opportunities for pharmacists.
    Batshon L
    Consult Pharm; 2010 Jun; 25(6):388. PubMed ID: 20534410
    [No Abstract]   [Full Text] [Related]  

  • 23. Toward permissionless innovation in health care.
    Adams AJ
    J Am Pharm Assoc (2003); 2015; 55(4):359-62. PubMed ID: 26161479
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacist provider status legislation: Projections and prospects.
    Harper PC
    J Am Pharm Assoc (2003); 2015; 55(2):203-7. PubMed ID: 25749265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FDA mulls expanded universe of nonprescription drugs.
    Traynor K
    Am J Health Syst Pharm; 2012 May; 69(9):734-5. PubMed ID: 22517017
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of diabetes medication adherence and healthcare costs in patients using mail order pharmacy and retail pharmacy.
    Devine S; Vlahiotis A; Sundar H
    J Med Econ; 2010; 13(2):203-11. PubMed ID: 20345227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Building a business plan to support a transplantation pharmacy practice model.
    Tichy EM; Pilch NA; Smith LD; Maldonado AQ; Taber DJ; ; ;
    Am J Health Syst Pharm; 2014 May; 71(9):751-7. PubMed ID: 24733139
    [No Abstract]   [Full Text] [Related]  

  • 28. The prescribing continuum: between prescription and over-the-counter drugs.
    Lyles A
    Clin Ther; 2007 Oct; 29(10):2244-5. PubMed ID: 18042481
    [No Abstract]   [Full Text] [Related]  

  • 29. Report of the 2009 APhA House of Delegates: actions of the legislative body of the American Pharmacists Association.
    J Am Pharm Assoc (2003); 2009; 49(4):492-4. PubMed ID: 19589759
    [No Abstract]   [Full Text] [Related]  

  • 30. Aid-in-dying practice in Europe and the United States: Legal and ethical perspectives for pharmacy.
    Varadarajan R; Freeman RA; Parmar JR
    Res Social Adm Pharm; 2016; 12(6):1016-1025. PubMed ID: 26711140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IACP's 2016 Compounders on Capitol Hill Asks.
    Int J Pharm Compd; 2016; 20(4):294-296. PubMed ID: 28333674
    [No Abstract]   [Full Text] [Related]  

  • 32. Legal aspects of expanded prescribing authority for pharmacists.
    Boatwright DE
    Am J Health Syst Pharm; 1998 Mar; 55(6):585-94. PubMed ID: 9544336
    [No Abstract]   [Full Text] [Related]  

  • 33. Recent developments in pharmaceutical products liability law: failure to warn, the learned intermediary defense, and other issues in the new millennium.
    Garbutt BJ; Hofmann ME
    Food Drug Law J; 2003; 58(2):269-86. PubMed ID: 12866558
    [No Abstract]   [Full Text] [Related]  

  • 34. New Medicare rule hedges on requiring pharmacist on transplantation team.
    Thompson CA
    Am J Health Syst Pharm; 2007 May; 64(10):1024, 1026. PubMed ID: 17494898
    [No Abstract]   [Full Text] [Related]  

  • 35. Adapting to a New Regulatory Environment.
    Baldwin P
    Consult Pharm; 2018 Apr; 33(4):228. PubMed ID: 29609702
    [No Abstract]   [Full Text] [Related]  

  • 36. How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A qualitative exploration.
    Guirguis LM; Makowsky MJ; Hughes CA; Sadowski CA; Schindel TJ; Yuksel N
    J Clin Pharm Ther; 2014 Aug; 39(4):390-8. PubMed ID: 24805908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health beliefs and over-the-counter product use.
    Häussinger C; Ruhl UE; Hach I
    Ann Pharmacother; 2009 Jun; 43(6):1122-7. PubMed ID: 19470857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent revisions to the State Operations Manual: implications for the management of urinary incontinence.
    Oliff L
    Director; 2007; 15(2):12-6. PubMed ID: 19343902
    [No Abstract]   [Full Text] [Related]  

  • 39. Lawmakers get big picture on pharmacy issues.
    Kertesz L
    AHIP Cover; 2008; 49(6):10, 67, 69. PubMed ID: 19180929
    [No Abstract]   [Full Text] [Related]  

  • 40. Medication adherence program: adherence challenges and interventions in type 2 diabetes.
    Odegard PS; Carpinito G; Christensen DB
    J Am Pharm Assoc (2003); 2013; 53(3):267-72. PubMed ID: 23699675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.